Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript
Karyopharm Therapeutics (NASDAQ: KPTI)
Q4 2023 Earnings Call
Feb 29, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Karyopharm Therapeutics Inc. Stock
€1.05
4.380%
We see a rather positive sentiment for Karyopharm Therapeutics Inc. with 7 Buy predictions and 2 Sell predictions.
With a target price of 3 € there is potential for a 185.58% increase which would mean more than doubling the current price of 1.05 € for Karyopharm Therapeutics Inc..